CD8+调节性T细胞对过敏性鼻炎患者外周血单个核细胞的影响
本研究为前瞻性横断面研究,纳入过敏性鼻炎患者,分离外周血单个核细胞中的CD4+和CD8+调节性T细胞体外培养。发现患者CD4+和CD8+ Treg比例降低,但培养上清IL-10和TGF-β及其mRNA升高;给予CD4+或CD8+ Treg后PBMC中IL-4和IL-5下降,且两种Treg效果无显著差异。结论提示CD8+ Treg可能减轻过敏性鼻炎的炎症反应。
要点
- 过敏性鼻炎患者外周血CD4+和CD8+ Treg比例低于正常人。
- 患者CD4+和CD8+ Treg培养中IL-10、TGF-β及其mRNA升高,两者无显著差异。
- CD4+或CD8+ Treg均可降低AR患者PBMC中IL-4和IL-5水平。
核心结论
- CD8+ Treg可能减轻过敏性鼻炎炎症反应。
研究设计与样本
- 前瞻性横断面研究,纳入过敏性鼻炎患者,分离外周血单个核细胞中的CD4+和CD8+ Treg进行体外培养。
主要发现
- AR患者CD4+和CD8+ Treg占总CD4+或CD8+ T细胞的比例较正常人降低。
- AR患者CD4+和CD8+ Treg培养中IL-10、TGF-β及其mRNA升高,两种Treg间无显著差异。
- AR患者PBMC中IL-4和IL-5较正常人升高,给予AR来源CD4+或CD8+ Treg后降低,两种Treg处理间无统计学差异。
临床怎么用
- CD8+ Treg可能作为过敏性鼻炎炎症调控的潜在靶点,但尚需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: CD8+ (or CD4+ ) CD25+ fork-head box transcription factor (Foxp3)+ regulatory T cells (CD8+ or CD4+ Tregs) all play a significant role in immune homeostasis and tolerance. However, the role of CD8+ Tregs in allergic rhinitis (AR) have not been clearly elucidated. The present study was aimed to assess the influence of CD8+ Tregs on peripheral blood mononuclear cells (PBMCs) from AR patients. STUDY DESIGN: Prospective cross-sectional study. METHODS: Patients with AR were enrolled. PBMCs were obtained, and CD4+ and CD8+ Tregs were separated from PBMCs and cultured in vitro. We examined percentages of these Tregs in total CD4+ or CD8+ T cells, respectively. After that, we evaluated levels of interleukin (IL)-10 and transforming growth factor (TGF)-β in Tregs cultures. Finally, we administered CD4+ and CD8+ Tregs from AR patients into PBMCs cultures and examined contents of IL-4 and IL-5. RESULTS: The percentages of CD4+ or CD8+ Tregs in the total CD4+ or CD8+ T cells from PBMCs in AR patients were reduced compared to normal subjects. However, IL-10 and TGF-β and their mRNAs were increased in CD4+ and CD8+ Tregs cultures from AR patients, and there were no significant differences in their levels between these two Tregs cultures. IL-4 and IL-5 were increased in AR subjects' PBMCs compared to normal ones and decreased after the AR CD4+ or CD8+ Tregs administration. However, there were no statistical differences in IL-4 and IL-5 concentrations between these two Tregs treatments. CONCLUSIONS: The findings demonstrate that CD8+ Tregs may alleviate inflammatory responses in AR condition. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E316-E323, 2021.
引用
- Lin L, Dai F, Wei J, et al. Influences of CD8+ Tregs on Peripheral Blood Mononuclear Cells from Allergic Rhinitis Patients. Laryngoscope. 2020. PMID: 32453455. doi:10.1002/lary.28759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。